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Abstract 
Purpose: The study compared the mechanical behavior of  bioresorbable polymeric 
stents with various designs during deployment, and investigated their fatigue 
performance under pulsatile blood pressure loading. Methods: Finite element 
simulations have been carried out to compare the mechanical performance of  four 
bioresorbable polymeric stents, i.e., Absorb, Elixir, Igaki-Tamai and RevaMedical, during 
deployment in diseased artery. Tri-folded balloon was modelled to expand the crimped 
stent onto the three-layered arterial wall with plaque. Cyclic diastolic-systolic pressure 
loading was applied to both stent and arterial wall to study fatigue behavior. Results: 
Stents with larger U-bend and longer axial strut demonstrate more flexibility but suffer 
from severe dogboning and recoiling effects. Stress concentrations in the stent, as well as 
in the plaque and artery, are higher for stents designed with increased rigidity such as 
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those with smaller U-bends and shorter axial struts. Simulations of  fatigue deformation 
for Elixir stent demonstrate that the U-bends, with high stress concentrations, have a 
potential risk of  fatigue failure under pulsatile systolic-diastolic blood pressure as 
opposed to the counter metallic stents which are normally free of  fatigue failure. 
Conclusion: The structural behaviour of  bioresorbable polymeric stent is strongly 
affected by its design, in terms of  expansion, dogboing, recoiling and stress distribution 
during the deployment process.  
 
Keywords: Bioresorbable polymeric stents; Stent expansion; Recoiling and dogboning, 
Fatigue life; Finite element. 
 
1. Introduction 
Stenting is a standard clinical procedure to treat blocked arteries and restore normal flow 
of  blood. Bioresorbable polymeric stents have attracted considerable interests recently, 
because they can provide lumen support for an appropriate period of  times and then 
disappear, leading to a reduction of  clinical complications (e.g. thrombosis, in-stent 
restenosis and inflammation) typically caused by metallic stents1. Bioresorbable polymeric 
stents are mostly made of  Poly-l-lactic acid (PLLA), which can break down to natural 
by-products (i.e., water, CO2, N2, biomass and inorganic salts) after biodegradation. 
Experimentally, there is a challenge to study mechanical properties of  stents due to their 
tiny sizes and complex geometries, and therefore finite element method has been largely 
used to simulate the deformation of  stents, including bioresorbable polymeric stents 
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although still limited. For instance, Pauck and Reddy2 conducted a computational analysis 
to investigate the radial strength, recoiling and radial stiffness of  PLLA coronary artery 
stent. Their results revealed that material modulus was an important parameter in 
determining the mechanics of  polymeric stent, and stent design (e.g., strut angle, 
thickness and width) also affected the mechanical behavior of  PLLA stent. Debusschere 
et al.3 used implicit finite element solver to model free expansion of  polymer stent and 
investigated how the balloon-inflation rate affected the mechanical integrity of  stent by 
considering viscoplastic behavior of  stent material. Results showed that direct 
balloon-inflation approach produced lower stresses on stent during expansion. Bobel et 
al.4 conducted bench test (i.e. radial crimping, bending and longitudinal compression) on 
three PLLA stents with different geometries to investigate their short-term mechanical 
performance, i.e., the radial strength, flexibility and longitudinal resistance, which were 
comparable to metallic stents. Recently, Bobel and Mchugh 5 performed computational 
modelling for PLLA stent deployment to evaluate recoiling behavior and material 
fracture as a function of  shape memory effect and stent deployment rate, and their 
results showed that the combined deployment method produced the best performance. 
Schiavone et al. 6 compared the mechanical behavior of  metallic stent (Xience) and 
polymeric stent (Absorb) during crimping and deployment in diseased artery using finite 
element method. The Absorb stent exhibited a lower expansion rate and higher 
recoiling/dog-boning effect than Xience, due to the difference in stent design and 
material property, but induced significantly less stresses to plaque and arterial wall. 
However, a comparative study of  polymeric stents with different designs is not available 
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according to our literature review. 
 
Commercially, due to the low market share and high cost, the Absorb bioresorbable 
vascular scaffolds (BVS) were withdrawn from the global market in Sept 2017. Besides, a 
series of  independent clinical trials have been completed to study the long-term 
outcomes for Absorb BVS, such as ABSORB China trial, ABSORB Japan trial and 
ABSORB Extend trial. Based on short-term (1 year) outcome, the Absorb BVS showed 
comparable clinical outcomes to metallic stents, which demonstrated the safety and 
efficacy of  BVS in the treatment of  coronary artery disease7, 8. However, disadvantages 
were found for the Absorb BVS in the long-term clinical outcomes (three years and 
beyond). For instance, Xu et al.9 reported the three-year clinical outcome of  the 
ABSORB China trial and found an increase in target lesion failure (by 0.3%) and stent 
thrombosis (by 0.9%) for Absorb BVS when compared to metallic Xience stent. This 
long-term deficiency was also reported at the Transcatheter Cardiovascular Therapeutics 
2018 conference, 21-25 September 2018, San Diego, California, United States of  
America10, 11. The exact cause of  the clinical problems has not been confirmed yet, but 
stent material and design are believed to play key roles in the long-term clinical 
performance for the Absorb BVS, including the process of  degradation and integrity 
loss12.  
 
In addition, stent fracture has been recognized and frequently reported in clinical studies. 
Initially, the occurrence of  stent fractures was reported in only 1%-2% of  patients 
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implanted with drug-eluting stents13. Recent studies showed higher incidence of  stent 
fracture with the significantly increased number of  stent implantations. For instance, 
Shaikh et al.14 addressed that there was 18.6% of  stent fracture observed in 188 patients 
implanted with drug-eluting stents over 12-month follow-up. Nakazawa et al.15 reported 
29% incidence of  stent fracture in 177 human lesions treated with drug-eluting stents 
over 630 days. The cause of  stent fracture is referred to dynamic biomechanical loads 
(i.e., tension, compression, bending and torsion), corrosive environment, stent materials 
and varied designs16. In particular, fatigue failure, caused by pulsatile blood pressure, 
plays an important role in the initiation of  fracture in stent. Arterial wall is subjected to 
approximately 70 times systolic-diastolic pulse in one minute, equivalent to ~40 million 
times in one year, as a result of  heart beating. 
 
The bioresorbable PLLA stents are designed for a lifetime of  two years, over which the 
polymer is absorbed by the human body via 3-stage hydrolytic degradation process. 
During the initial stage, the polymer undertakes water via gradual diffusion, which leads 
to slight reduction of  molecular weight but without a loss in mass and mechanical 
strength. At the second stage, a significant reduction of  molecular weight is observed 
due to the hydration of  polymer, while the change of  mechanical strength is still limited. 
At the third stage, both mechanical strength and mass reduce significantly because of  
scission of  the amorphous tie chains17, 18. Therefore, stent properties experience 
significant change only in the 3rd stage, which is generally towards the end of  their 
lifetime (2 years). It is well known that the stented-artery is subjected to approximately 70 
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systolic-diastolic pulses in one minute (~40 million cycles in one year) due to heart 
beating. Therefore, it is important to study the fatigue failure of  bioresorbable polymeric 
stents during their life time.  
 
Computational approaches have been used to assess fatigue behaviour of  metallic stents. 
Li et al.19 simulated L605 Co-Cr stent deformation under fatigue loading and evaluated 
the fatigue life based on Goodman’s rule. Their results showed that dangerous points 
were located at the U-bends of  the ring struts. Azaouzi et al. 20 carried out fatigue life 
prediction of  316L stainless steel stent by means of  two approaches, i.e., the well-known 
Goodman’s diagram and the theory of  critical distance. They simulated stent deployment 
in blood vessel, and addressed that stent failure might happen during either the initial 
deployment of  stent or the long period of  pulsatile loading after stent deployment. 
Recently, Dordoni et al. 21 introduced a principal strain-based criterion for fatigue 
assessment of  nitinol stent, with calibration against fatigue experiments. Results showed 
that the most stressed zones were located at the link area and the V-strut directly 
connected to the link area. However, almost all existing work focused on metallic stents, 
such as Co-Cr, stainless steel and nitinol stents, and there is a lack of  study on the fatigue 
behavior of  polymeric stents. 
 
In this paper, deployment of  four bioresorbable polymeric stents, i.e., Absorb, Elixir, 
Igaki-Tamai and RevaMedical stents, in stenotic artery was simulated using finite element 
method. This study aimed to compare the mechanical performance of  four stents with 
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different designs during the deployment process. In particular, stress distribution on 
stents, change of  stent diameter against pressure and stent recoiling/dogboning effects 
were characterized and compared. Furthermore, fatigue failure of  polymeric stent was 
also investigated, which is the first time according to our best knowledge in this area. 
 
2. Methodology 
2.1 FE models for stent and stenotic artery 
Four different bioresorbable polymeric stents were considered in this paper, namely, 
Absorb (Abbott Vascular), Elixir (Elixir Medical), Igaki-Tamai (Kyoto Medical) and 
RevaMedical (REVA Medical) stents. Geometrical models of  the four stents, in fully 
expanded shape, were created using Abaqus 6.14 CAE (see Figure 1). Generally, stent 
geometry is defined by three parameters, i.e., axial strut (bridge strut), U-bend strut 
amplitude and U-bend strut radius, as shown in Figure 2. In this research, Absorb, Elixir 
and RevaMedical stents, have the same radius and amplitude for the U-bend struts, while 
the Igaki-Tamai has larger amplitude and smaller radius for U-bend struts. The 
connective axial strut spacing is also similar for Absorb, Elixir and RevaMedical stents, 
while the Igaki-Tamai stent has larger axial strut spacing. The geometries and strut 
thickness of  these four stents were taken from various open resources, as summarized in 
Table 1. The outer diameter and the length of  the stents were chosen to be 3 mm (in 
expanded shape) and 12 mm, respectively. These stent models were meshed using 3D 
8-node hexahedral elements with reduced integration (C3D8R). The mesh density 5×4 (5 
layers through width direction and 4 layers through thickness direction) was used, 
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because mesh sensitivity study was undertaken to confirm that convergence was achieved 
for the stent with mesh density 4×4. 
 
 
Figure 1, 3D models for (a) Absorb, (b) Elixir, (c) Igaki-Tamai and (d) RevaMedical 
stents with mesh. 
 
 
Table 1, Summary of  parameters and dimensions for the four stents. 
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Figure 2, Stent design parameters, h is the axial strut, f  is the amplitude of  U-bend strut 
and ρ is the radius of  U-bend strut. 
 
A three-layer artery was modelled, with an inner diameter of  3 mm and a length of  40 
mm. The overall thickness of  arterial wall is 1 mm, including 0.38 mm for adventitia layer, 
0.33 mm for media layer and 0.29 mm for intima layer. The artery consists of  three layers 
(adventitia, media and intima) according to histology analysis. The thickness of  each layer 
was taken from Holzapfel et al.22, who measured 55 coronary artery samples from 13 
patients. The length of  artery was chosen to be 40 mm to mitigate the influence of  
boundary constraints in the finite element modelling23, 24. Plaque was modelled as a 
symmetric wall inside the artery, with a length of  10 mm and a stenosis of  50% (inner 
diameter is 1.5 mm). Hexahedral element with reduced integration (C3D8R) was used to 
mesh the artery and plaque. In the radial direction, the artery was meshed with 4 layers 
of  elements for each arterial layer and the plaque was meshed with 8 layers of  elements. 
In the longitudinal direction, the element size along the artery was increasing from the 
middle to both ends using a biased-seeding method. Figure 3 shows the mesh and 
geometry for plaque-artery system. 
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Figure 3, FE mesh for the plaque-artery system. 
 
2.2 Constitutive models for stent and stenotic artery 
In this study, biodegradable polymer PLLA was taken as the material for all four stents. 
The mechanical behavior of  bioresorbable polymer PLLA used in the finite element 
model of  stent was described by the uniaxial tensile stress-strain curve, which consisted 
of  both elastic and plastic deformation. For elastic deformation, Young’s Modulus (2200 
MPa) and Poisson’s ratio (0.3) were used in the simulation. Plastic deformation was 
considered by providing the yield stress as a function of  plastic strain (i.e., isotropic 
hardening), extracted from the stress-strain curve in Pauck and Reddy2. In addition, the 
density of  material PLLA is 1.4×10-6. 
 
For the three-layer artery, the Gasser-Ogden-Holzapfel model25, 26 was used to describe 
the anisotropic behaviour of  the arterial layers with collagen fibers, and the strain energy 
potential function is expressed by: 
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where U is the strain energy per unit of  reference volume, C10, D, k1, k2 and κ are 
temperature-dependent material parameters, N is the number of  fiber families, I1 is the 
first deviatoric strain invariant, J is the elastic volume ratio, I(4(αα)) is the invariant of  
Cauchy-Green deformation tensor and Eα represents the deformation of  the fiber 
families. The operator <> stands for the Macauley bracket. 
 
The constitutive model was calibrated by fitting the averaged stress-stretch curves 
obtained form 13 patients22, and the calibrated parameter values for the 
Gasser-Ogden-Holzapfel model were given in Table 2. In this study, it is assumed that 
there are two families of  collagen fibers embedded in a soft incompressible ground 
matrix within each arterial layer, i.e., N = 2. The parameter γ in Table 2 (related to Iସ(஑஑) 
in Eq. (1)) represents the angle between the mean orientation of  the fibers and the 
circumferential direction, so it is measured from the circumferential direction. The values 
of  γ were taken from Holzapfel et al.22, who gave an average value for arterial layer 
samples taken from 13 patients. It should be noted that the γ-parameter values given in 
Holzapfel et al.22 may not represent exactly the same mean fiber orientation as those in 
the Gasser-Ogden-Holzapfel model26, but they have similar physical meanings. The 
parameter κ in Eq. (1) represents the level of  fiber dispersion, which was firstly 
introduced in the Gasser-Ogden-Holzapfel model by Gasser et al.26. It is believed that 
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fiber distribution varied significantly from patients to patients. As direct measurements 
of  fiber distribution were not available for the patients studied in Holzapfel et al.22, the 
calibration of  parameter κ  was purely based on comparison of  the simulated 
stress-stretch response, in both circumferential and longitudinal directions, against the 
experimental data reported in Holzapfel et al22. So the values of parameter 𝜅 in Table 2 
may not reflect the actual fiber dispersion in the tissue. Nevertheless, the values in Table 
2 were able to give a matched description of  the anisotropic response of  the tissue 
(circumferential and longitudinal direction), as shown in Figure 4. Also in this work, we 
studied the stress distributions at a macroscopic level instead of  fiber level, therefore the 
calibrated model should be able to capture the response of  the tissue properly. In future 
work, the value of κ should be assessed against histological data of  fiber distribution in 
arterial layers. 
 
It should be noted that the Gasser-Ogden-Holzapfel model26 incorporates fiber 
dispersion, but it may cause some unphysical behavior due to the treatment of  fiber 
tension-compression behavior under deformation in which the fibers under compression 
cannot be excluded correctly. To resolve this issue, Holzapfel and Ogden 27 introduced a 
tension-compression switch to the model, which neglects the contribution of  fibers 
under compression. Specifically, they applied an angular integration approach to model 
the distribution of  dispersed fibers, and computational studies showed that the exclusion 
of  the compressed fibers made a significant difference to the elastic response of  the 
tissue28. Recently, they also introduced a discrete fiber dispersion model to exclude fibers 
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under compression (i.e., in a discrete manner), and computational implementation of  this 
model produced accurate results for a unit cube under simple tension and shear as well as 
for a rectangular strip under non-homogeneous uniaxial extension29. This will need to be 
considered in future simulations of  stent deployment in diseased artery. 
 
For hypocellular plaque, the constitutive behaviour was defined in the form of  first-order 
hyperelastic Ogden strain energy potential30, and the material parameters were calibrated 
against experimental data31. Further details, regarding the model parameters and 
comparison between model simulations and experimental data, can be found in our 
previous study6, 32. 
 
Table 2, Parameter values of  the anisotropic hyperelastic Gasser-Ogden-Holzapfel 
model6. 
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Figure 4, Longitudinal and circumferential stress-stretch responses: simulation results vs. 
experimental data. 
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2.3 Modelling of  stent deployment 
Simulation of  stent deployment was divided into four steps: crimping, spring back, 
balloon inflation and deflation. The stent was crimped onto the tri-folded balloon by 
applying enforced displacement on the 12 rigid plates constructed around the stent. After 
crimping, the rigid plates were removed to allow the recovery of  elastic deformation for 
the crimped stent. The inflation step was performed by applying pressure on the inner 
surface of  balloon. The uniform pressure was linearly increasing from 0 to 1.4 MPa. 
Both ends of  artery were fully constrained to reflect the constraint imposed by the 
human body environment. Interactions between the artery, stent and balloon were 
modelled as surface to surface hard contacts with a frictional coefficient of  0.25. The 
deflation step was modelled by linearly releasing the pressure on the inner surface of  
balloon, which allowed the expanded stent to recoil freely. Interactions between stent, the 
balloon and the plaque were maintained in this step.  
 
It should be noted that the residual stress in the arterial wall can be considered with a 
generalized prestressing algorithm reported in Pierce et al33. Specifically, an incremental 
update of  displacement field in the classical approach is replaced by an incremental 
update of  displacement gradient34,35. This method allows for an incorporation of  residual 
stresses into the finite element model without changing the original geometry33. However, 
the residual stress of  the arterial wall was not considered in our model, a limitation of  
the current study. Further research is required to incorporate the residual stress 
appropriately into our simulations. 
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2.4 Fatigue deformation analysis 
In order to study fatigue behaviour of  stent under pulsatile blood pressure, two 
simulation steps, i.e., pre-loading and cyclic loading steps, were added following the 
deployment of  stent. During these two steps, contact between stent and balloon was 
removed while contact between stent and artery was maintained. Both ends of  artery 
were still fully constrained over the process. Normally, the realistic blood pressure has a 
mean value of  100 mmHg (0.0125 MPa), fluctuating between a diastolic value of  80 
mmHg (0.01 MPa) and a systolic value of  120 mmHg (0.015 MPa). In this study, the 
systolic-diastolic blood pressure followed a realistic waveform. Figure 5 shows the 
pressure pulse at the inlet of  ascending aorta under normal pressure condition, which 
was taken from Vasava et al36. The time for single heart beat is 0.85 s, and the waveform 
includes two peaks in one cycle. In the pre-loading step, blood pressure was applied on 
the inner surfaces of  both stent and artery with a linear increase from zero to 0.01 MPa 
(diastolic value), and then diastolic-systolic pressure loading was imposed to simulate 
cyclic deformation of  the system (i.e., cyclic loading step). 
 
Figure 5, Blood pressure in the realistic waveform under normal condition36. 
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3. Results 
3.1 Stent expansion 
Stent expansion has been monitored by tracking the diameter change against radial 
pressure for four stents during deployment process (Figure 6). Generally, the stent 
diameter increases slightly during the initial inflation stage, followed by a fast expansion 
stage and then a saturation stage with the increasing pressure. The four stents experience 
different expansion rates during balloon inflation process. The Igaki-Tamai stent expands 
with the highest rate and reaches saturation earliest (at a pressure of  0.2 MPa), while the 
RevaMedical stent expands with the lowest rate and reaches saturation latest (at a 
pressure of  0.8 MPa). The Absorb and Elixir stents show similar expansion behaviour, 
and reach saturation at a pressure of  0.6 MPa. At the peak inflating pressure, the 
Igaki-Tamai stent achieves a diameter of  2.96 mm, while the RevaMedical stent expands 
to a diameter of  2.62 mm. The achieved diameter is 2.68 mm for the Elixir stent and 
2.70 mm for the Absorb stent. After releasing the balloon pressure, stent diameter 
experiences a gradual decrease in all cases, leading to a recoiling effect. This is caused by 
the recovery of  elastic deformation of  the stents during expansion. As shown in Figure 7, 
the recoiling effect is 17% for the Absorb and Elixir stents, 23% for the Igaki-Tamai 
stent and 15% for the RevaMedical stent. After balloon deflation, the final diameter is 
measured to be 2.22 mm for the Absorb stent, 2.20 mm for the Elixir stent, 2.28 mm for 
the Igaki-Tamai stent and 2.25 mm for the RevaMedical stent. 
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Figure 6, Diameter change against pressure for the four stents during deployment. 
 
 
Figure 7, Recoiling effects for the four stents after balloon deflation. 
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The stresses developed in the four stents after deployment are compared in Figure 8 via 
contour plots of  von Mises stress. Significant level of  stress has been developed in the 
stent in all cases, with a maximum value of  around 100 MPa. Stress concentrations are 
located at the crests of  U-bends, as indicated by red colour.  
 
Also, all four stents show the dogbone shapes caused by the nonuniform expansion of  
the stents. Dogboning effect is mainly caused by the shrinkage of  the plaque after 
balloon deflation, which becomes the most severe at the middle of  the plaque due to the 
confinement of  surrounding tissue (i.e., bulk constraint). This imposed the most radial 
compression to the middle part of  the stent, leading to the dogboning effect. In addition, 
the length of  stent is always longer than that of  plaque, which also contributes to the 
dogboning effect as the ends of  stent experience less radial compression after 
deployment. he dogbonig effect is determined by calculating the difference between 
diameters in the middle and at the end37: 
 𝑑𝑜𝑔𝑏𝑜𝑛𝑖𝑛𝑔 (%) =
(𝑑௘ − 𝑑௠)
𝑑௠
× 100% (3) 
where 𝑑௘ is the average diameter at the end of  stent and 𝑑௠ is the average diameter in 
the middle of  stent. As shown in Figure 9, the Absorb and Elixir stents experience the 
most severe dogboning (i.e., 35%), while the RevaMedical stent has the least dogboning 
effect (i.e., 17%). The Igaki-Tamai stent shows a dogboning of  23%. 
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Figure 8, Contour plots of  von Mises stress (MPa) for the four stents after balloon 
deflation. 
 
 
Figure 9, Dogboning effects for the four stents after balloon deflation. 
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3.2 Stresses in the plaque/artery 
Figures 10 and 11 show the von Mises stress contour plot on the plaque and artery at 
peak inflating pressure during the deployment of  the four stents. The maximum von 
Mises stress on the plaque was 3.91 MPa for the Absorb stent, 3.83 MPa for the Elixir 
stent, 5.88 MPa for the Igaki-Tamai stent and 3.46 MPa for the RevaMedical stent. The 
maximum von Mises stress on the artery was 15.30 MPa for the Absorb stent, 15.85 MPa 
for the Elixir stent, 20.19 MPa for the Igaki-Tamai stent and 13.80 MPa for the 
RevaMedical stent. The high levels of  stresses on plaque and arterial layers suggested a 
potential damage in the native tissue of  arterial wall during stent deployment, and 
therefore damage of  arterial wall should be considered in order to properly capture the 
deformation characteristics of  the vessel. This requires a significant amount of  additional 
efforts, in terms of  formulating a new constitutive model for the tissue, which is beyond 
the scope of  current study.  
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Figure 10, The von Mises contour (MPa) plot on plaque at peak pressure: (a) Absorb, (b) 
Elixir, (c) Igaki-Tamai and (d) RevaMedical stents. 
 
 
Figure 11, The von Mises contour (MPa) plot on three-layer artery at peak pressure: (a) 
Absorb, (b) Elixir, (c) Igaki-Tamai and (d) RevaMedical stents. 
 
High levels of  stresses have also been developed in the plaque and artery following the 
stenting process. For the plaque (Figure 12), stress concentration is noticed at both ends 
of  the plaque. The maximum von Mises stress on the plaque is 1.04 MPa, 0.89 MPa, 1.41 
MPa and 1.35 MPa for the Absorb, Elixir, Igaki-Tamai and RevaMedical stents, 
respectively. For the artery (Figure 13), the stress has a visible gradient from the intima 
layer to the adventitia layer. Stress concentration is mainly located in the intima layer of  
the artery in all four simulations. The maximum von Mises stress is 0.17 MPa, 0.16 MPa, 
0.40 MPa and 0.29 MPa for the artery expanded with the Absorb, Elixir, Igaki-Tamai and 
RevaMedical stents, respectively. 
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Figure 12, The von Mises contour (MPa) plot on plaque after balloon deflation: (a) 
Absorb, (b) Elixir, (c) Igaki-Tamai and (d) RevaMedical stents. 
 
 
Figure 13, The von Mises contour (MPa) plot on the three-layer artery after balloon 
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deflation: (a) Absorb, (b) Elixir, (c) Igaki-Tamai and (d) RevaMedical stents. 
3.3 Stent deformation due to pulsatile blood pressure 
During the cyclic systolic-diastolic loading step, the maximum von Mises stress is located 
at critical element A and the maximum equivalent plastic strain occurs at critical element 
B, as indicated in Figure 14. In order to investigate the fatigue behaviour of  stent, stress 
variations of  these two elements are required. Figure 15 shows the von Mises stress 
variation against step time for the critical element A subjected to cyclic systolic-diastolic 
loading. It is clear that the von Mises stress shows a significant fluctuation under the 
cyclic systolic-diastolic loading and intend to stabilize at cycle 5. The maximum and 
minimum stabilized stresses are 100 MPa and 92 MPa, respectively, which gives a stress 
amplitude of  4 MPa (i.e., a stress range of  8 MPa). 
 
 
Figure 14, Stent model showing locations of  critical elements A and B with maximum 
von Mises stress and with maximum equivalent plastic strain, respectively. 
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Figure 15, Diagram of  von Mises stress variation for critical element A during 
systolic-diastolic cyclic loading process. 
 
3.4 Fatigue life assessment 
Fatigue life prediction is of  importance because cyclic load may lead to a failure of  
component at much lower stress compared to that under monotonic loading condition. 
Stress-life (S-N) method is usually used to determine the fatigue life of  materials and 
components. The fatigue testing data of  polymer PLLA studied here are not available, 
and therefore the S-N curves of  several other polymers are considered to estimate the 
fatigue life of  Elixir stent, as shown in Figure 16 38,39. The red line represents the stress 
amplitude of  critical element on stent under cyclic systolic-diastolic loading condition, 
and the black lines illustrate the existing fitted S-N curves of  polymers, including Epoxy 
(EP), polyethylene terephthalate (PET), poly-lactic acid (PLA), polystyrene (PS), 
polymethyl methacrylate (PMMA), polypropylene (PP), polyethylene (PE) and 
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polytetrafluoroethylene (PTFE). The fatigue limit can be obtained for EP, PS and PP 
from the diagram, which was 20 MPa, 10 MPa and 5 MPa, respectively. The S-N curve of  
PLA does not exhibit a saturation stage, and therefore the specified fatigue limit cannot 
be determined. However, the fatigue limit of  PLA can be assumed to be between those 
for polymer EP (20 MPa) and PP (5 MPa). The stress amplitude of  critical element A can 
be calculated from the variation of  von Mises stress, which is 4 MPa and even lower than 
the fatigue limit of  PP (5 MPa). This suggests that critical element A is located within 
infinite life stress zone. It should be noticed that the fatigue life prediction is performed 
based on testing data up to 107 cycles. 
 
 
Figure 16, Stress amplitude vs. cycles to failure (S-N) curves for EP, PET, PLA, PS, 
PMMA, PP, PE and PTFE. 
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The above analysis is only valid when the mean stress is zero. In FE analysis, a significant 
level of  mean stress is obtained for stent due to excess deformation in the deployment 
stage. Consequently, the Goodman analysis method can be considered to assess the 
fatigue life of  stent. The Goodman’s rule combines the mean stress and stress amplitude, 
which is defined by: 
 
𝜎௔
𝑆௔
+
𝜎௠
𝑆௨
= 1 (4) 
where 𝜎௠ and 𝜎௔ represent the mean stress and stress amplitude of  applied cyclic 
stress, and 𝑆௔  and 𝑆௨  are the fatigue limit (fatigue strength) and ultimate tensile 
strength of  the material. The ultimate tensile strength of  PLLA was taken as 105 MPa 
based on the experimental data of  Pauck and Reddy2.  
 
The mean stress and stress amplitude of  all elements can be obtained from the FE 
analysis of  stent deformation during cyclic systolic-diastolic loading. They are plotted in 
the Goodman’s diagram, as shown in Figure 17. The blue and orange lines represent the 
fatigue limit lines of  PLLA, which were determined by estimating the fatigue limit in a 
range of  10 MPa and 20 MPa. In fact, the fatigue limit for medical grade PLLA is not 
available. The range chosen here is based on the values reported for PLA (see Figure 16), 
where the S-N curve tends to reach a saturation at a stress amplitude between 10 MPa 
and 20 MPa. Generally, the zone below fatigue limit line means safe zone, i.e., free from 
fatigue failure. The green square symbols represent the level of  mean stress and stress 
amplitude of  all elements and the red triangle symbol represents the critical element A 
which has the highest level of  mean stress and stress amplitude. It can be observed that a 
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large number of  elements experience high levels of  mean stress and stress amplitude 
during the cyclic systolic-diastolic loading. A group of  elements are already located in the 
dangerous zone based on the estimated fatigue limit lines, and possess a risk of  fatigue 
failure. 
 
 
Figure 17, Goodman’s diagram for the Elixir stent. 
 
4. Discussions 
4.1 Effect of  design on stent expansion 
The stent-diameter change against pressure shows differences for the four stents. The 
material properties are the same for all four stents, but they require different pressure to 
achieve the same diameter. For instance, to achieve a diameter of  2.5 mm, the pressure 
required is 0.3 MPa for Igaki-Tamai stent, 0.6 MPa for Elixir stent, 0.7 MPa for Absorb 
stent and 1 MPa for RevaMedical stent. This indicates that design is an important factor 
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that influences the expansion behavior of  stent. Design of  stent usually involves the 
shape, size and length of  U-bend struts and axial struts. The radius and amplitude of  
U-bend strut make a difference to the radial expansion behavior of  stent, and larger 
U-bend radius and amplitude make the stent easier to expand. The axial struts affect 
stent behavior in the longitudinal direction during expansion, and longer axial struts 
facilitate deformation in the axial direction during stent deployment. 
 
Recoiling effect is observed for all stents after balloon inflation, and stents experience 
different recoiling effects due to their individual designs. Particularly, the Igaki-Tamai 
stent show the most severe recoiling effects when compared to the other three stents. It 
is because the Igaki-Tamai stent is made of  sharper U-bend struts and longer axial struts, 
which makes it more flexible to deform during crimping and expansion processes. The 
Absorb and Elixir stents have the same U-bends and axial strut length, and therefore 
they experience almost the same recoiling effects. The RevaMedical stent has the same 
U-bend as the Absorb and Elixir stents, but its axial struts have a middle-to-middle 
connective design that enhances the stent rigidity, resulting in the lowest recoiling effect. 
 
Similarly, the four stents experience different dogboning effects, which is mainly caused 
by design difference. For instance, the Absorb and Elixir stents have the almost same 
design, which results in almost the same dogboning effect (35%). The Igaki-Tamai stent 
has longer axial strut and sharper U-bend strut, making it easier to expand and recover in 
the radial direction, thus less dogboning effect (23%). For RevaMedical stent, it has the 
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same U-bend strut as the Absorb and Elixir stents, but curved axial strut which gives it 
more freedom to deform and recover, and therefore a significantly reduced dogboning 
effect (17%) is obtained after the deployment process.  
 
4.2 Stress distribution in the stent-artery system 
The stress states of  stent-artery system also show some difference during the 
deployment of  the four stents. The maximum von Mises stress are very close for all four 
stents during expansion processes, but less stress concentration areas are observed for 
the Igaki-Tamai stent due to its longer axial strut and larger amplitude of  U-bends. With 
the distinct design, the Igaki-Tamai stent achieves the largest final diameter after balloon 
deflation, and thus contributes more expansion to the artery. As a result, the artery has 
the highest level of  stresses during the deployment of  the Igaki-Tamai stent. The Absorb 
and Elixir stents, with similar peak-to-peak connecting strut designs, induce the same 
degree of  expansion to artery. A slightly less expansion of  artery is generated during the 
deployment of  RevaMedical stent, due to its middle-to-middle connecting strut design.  
 
High level of  stresses is generated in the plaque/artery during the deployment of  stent. 
Timmins et al.40 addressed that excessive vessel stresses induced by stenting might lead to 
adverse arterial reaction, damage and even restenosis. Bedoya et al.41 concluded that stent 
designs, with large axial strut spacing, blunted corners and large amplitudes of  U-bends, 
would produce less stress concentration regions on the artery. In this study, the 
Igaki-Tamai stent, with long axial strut but sharp U-bend, generates more severe stress 
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on the plaque/artery during its implantation in artery. It is due to the largest diameter 
achieved by the Igaki-Tamai stent during deployment process, facilitated by the longer 
axial and sharper U-bend struts in the stent design. So, stent design also plays an 
important role in the level of  stresses induced to the artery/plaque during stent 
deployment. 
 
4.3 Fatigue behaviour of  stent 
Firstly, stress concentration occurs at the inner corner of  stent U-bends and low stress is 
found at the bridge struts during cyclic systolic-diastolic loading. This phenomenon is 
also reported in the study of  fatigue of  metallic stents. For instance, Li et al.19 studied 
fatigue behavior of  Co-Cr stent and found that the high stress areas were distributed in 
the curvatures of  stent rings whereas minimal stress regions happened at the middle 
position of  bridge struts. They predicted that the dangerous position of  stent structure 
was at the curvature of  rings due to the high stress levels, which was also verified by 
fatigue experiments. As discussed in the previous section, stress concentration occurs at 
the curvature (corner) of  stent U-bends and high residual stress is generated during stent 
crimping and deployment processes. Thus, residual stress caused by stent expansion 
imposes a high level of  mean stress, and acts as a key factor influencing the fatigue 
resistance of  the stent structure in cyclic loading condition. 
 
Fatigue life of  stents usually refers to 107 cycles due to the typical annual heart beating of  
4×107 cycles/year. In this study, the fatigue life was assessed against a life of  107 cycles 
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using the S-N curves of  selected polymers, and therefore the prediction is valid for at 
least a period of  one year. The result is meaningful because the Elixir stent will degrade 
after one year. Certainly, fatigue behaviour of  polymer can also be affected by 
environment, temperature and frequency of  loading 38. However, this study didn’t 
consider the effect of  temperature and frequency because the corresponding fatigue test 
data are not available. Therefore, to achieve comprehensive understanding of  stent 
fatigue, further work is required, especially fatigue testing of  PLLA and its structural 
components. 
 
Moreover, the Goodman’s rule has been used to conduct fatigue life prediction for stent, 
by evaluating the mean stress and stress amplitude distribution. In the Goodman’s 
diagram, the fatigue limit line is determined by fatigue strength and ultimate tensile 
strength of  the material. This study carried out fatigue life prediction of  polymeric stent 
based on the stress state of  all elements, and highlights that there is a risk of  fatigue 
failure in the U-bend regions due to high levels of  mean stress and stress amplitude. But 
for metallic stent (e.g. L605 Co-Cr alloy or 316L stainless steel), FE simulations 
suggested that there was no risk of  fatigue failure under the systolic-diastolic loading 
condition19, 38. This may due to the difference in material properties. The L605 Co-Cr 
alloy and 316L stainless steel have significantly higher fatigue strength (300 MPa and 115 
MPa) and ultimate tensile strength (1390 MPa and 580 MPa), compared to polymer 
PLLA. This suggests that material properties, such as fatigue strength and ultimate 
tensile strength, also play an important role in the fatigue resistance of  stents. On the 
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other hand, it may also be due to the difference in the applied cyclic systolic-diastolic 
loads. Some of  them considered the cyclic load that was applied on the outer surface of  
stent without an artery, and others included artery in the model but only applied cyclic 
loading on artery. In this study, cyclic systolic-diastolic load has been imposed on both 
the stent and artery which are in direct contact with the blood flow. 
 
4.4 Validation 
It should be noted that experimental data regarding stent deployment and 
post-implantation fatigue performance are not available for direct validation of  our 
computational studies. However, comparisons were made against those reported for 
ABSORB stent in the work of  Schiavone et al.24, which are in good agreement in terms 
of  the stress distribution and magnitude on the stent. In our study, stent recoiling 
behavior was also compared with those reported in Pauck and Reddy 2 for PLLA stent 
with similar design, and a good match was obtained (i.e., 35% for ABSORB in this study 
vs. 31% for S1 stent in Pauck and Reddy 2; 23% for Igaki-Tamai in this study vs. 22% for 
S3 stent in Pauck and Reddy 2). In addition, stress distributions on stent are in good 
agreement with those reported in Debusschere et al. 3 for a PLLA stent. In addition, 
fatigue analyses presented in this study are in good agreement with the work of  Li et al.19, 
confirming the risk of  strut U-bends to fatigue failure for both metallic and polymeric 
stents. For fatigue, Dreher et al. 42 tested the fatigue life (up to 1.2107 cycles) for a PLLA 
stent subunit (U-bend) subjected to displacement-controlled cyclic loading. The work 
confirmed the fatigue failure of  U-bend unit, exhibiting a decreased life with increasing 
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loading amplitude. In addition, it was also shown that fatigue loading significantly 
increased the chemical degradation rate of  the PLLA stent, further promoting fatigue 
failure. Clinically, Yamaji et al.43 reported that the leading mechanism for very late 
thrombosis was scaffold discontinuity, which was associated with the loss of  structural 
integrity (e.g., under radial pressure and fatigue) of  bioresorbable scaffolds during 
degradation. 
 
Experimental studies of  mechanical performance of  stents, including in vitro and in vivo 
measurements, are currently ongoing in our research group, which will be utilized for 
model validation in future work. Also, in this work, the pulsatile loading was applied to 
both stent and plaque-artery as described in Section 2.4, and the fatigue simulations 
considered the full interaction between the stent and the plaque-artery. Therefore, the 
pulsatile stresses obtained for the stent included the effects of plaque-artery under fatigue 
deformation. 
 
5. Conclusions 
In this paper, the full process of  stent deployment in diseased artery has been simulated 
for four bioresorbable polymeric stents, i.e., Absorb, Elixir, Igaki-Tamai and RevaMedical 
stents. Furthermore, fatigue deformation of  implanted Elixir stent was simulated under 
cyclic systolic-diastolic blood pressure loading. The maximum von Mises stress and stress 
amplitude were found at the crests of  stent U-bends, indicating a risk of  fatigue failure. 
The Goodman’s method was used to carry out fatigue life prediction, and the results 
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suggested potential fatigue failure at the U-bend regions of  polymer stent. However, the 
fatigue assessment has some limitations due to the lack of  testing data for PLLA, and 
therefore further work is required in terms of  material characterization and fatigue 
testing. 
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